Abstract This review is a continuation of suggested tumor additions to the next WHO Tumor Classification. The author will focus on four salivary gland entities that have recently become accepted in the literature as new neoplastic entities: sclerosing polycystic adenosis, mammary analogue secretory carcinoma, cribriform adenocarcinoma of the tongue and other sites, and mucinous variant of myoepithelioma.
Introduction
The last World Health Organization (WHO) Head and Neck Tumor Classification was published in 2005. Since this time there have been several new entities described in the literature worthy of including in the next edition. This review will briefly describe four of these: sclerosing polycystic adenosis (SPA), mammary analogue secretory carcinoma, cribriform adenocarcinoma of the tongue and other sites, and the mucinous variant of myoepithelioma.
Sclerosing Polycystic Adenosis
Sclerosing polycystic adenosis (SPA) is a recently described, rare, reactive/neoplastic, inflammatory process of the major or minor salivary glands that is similar to fibrocystic changes, sclerosing adenosis and adenosis tumors of the breast. Both have cystic components with a prominent lobular or multilobular arrangement often with small, proliferating, closely packed ductal structures, surrounded by a peripheral myoepithelial layer. Similar to breast, the salivary gland tumors may be associated with ductal epithelial hyperplasia and atypia, ranging from mild dysplasia to severe dysplasia/carcinoma-in situ.
Smith et al. [1] first reported SPA in 1996, describing nine patients from the files of the Armed Forces Institute of Pathology. Since this report, there have been several smaller series and case reports with the largest series of 16 cases published by Gnepp et al. [2] .
To date, there are 63 cases reported [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . Patients range in age from 9 to 84 years with a male to female ratio of 27:36. Forty-six tumors involve the parotid gland, five the submandibular gland, nine various sites of the oral cavity, two the nasal cavity and one the lacrimal gland. Patients typically present with a slow growing mass with occasional tenderness, mild pain or a ''tingling'' sensation. On gross exam, tumors are firm, rubbery, well circumscribed and frequently are embedded in normal salivary gland. Occasional tumors are multinodular; one patient presented with two separate masses [6] . Tumors range from a few millimeters to 7 cm in greatest dimension at initial presentation.
Microscopically tumors are well circumscribed, with multiple, densely sclerotic, irregularly defined lobules composed of abundant hyalinized collagen surrounding variably sized collections of ducts with cystic change.
Occasional tumors are composed of one large lobule with numerous ducts surrounded by prominent sclerosis. The density of ductal elements and degree of cystic change varies within and between cases with some cases having abundant fibrous stroma separating each of the ducts; other cases demonstrate more closely packed ductal elements, including foci of closely packed small ductular elements similar to sclerosing adenosis of the breast (Fig. 1) . Rarely, the lobular architecture is somewhat effaced by the epithelial proliferation and marked fibrosis. Ducts may be lined by flattened to cuboidal epithelium. Hyperplasia of ductal and acinar elements and areas of apocrine-like metaplasia are common (Fig. 1e) . Mucin containing, squamous, sebaceous-like and ballooned cells occasionally line ducts and cystic spaces. Atrophic and normal salivary gland acini are frequently found between and inside of the lobules. Brightly eosinophilic, intracytoplasmic modified zymogen granules are found in some tubuloacinar structures (Fig. 1e) . The intraluminal epithelial proliferation infrequently form a cribriform pattern, some of which is associated with nesting basement membrane-like material.
Occasional cases demonstrate prominent areas of central intraductal necrosis and regions with prominent, atypical acinar cell proliferation with foci of a microcystic or solid pattern to a degree that mimics acinic cell carcinoma. These atypical foci contain dysplastic ductal epithelium ranging to severe dysplasia/carcinoma in situ (Fig. 1f) . Although these areas are atypical, lobular architecture is always maintained and invasive growth is not found. Rarely, however, ductal distortion and atypia mimics an infiltrative pattern.
Immunohistochemistry demonstrates preservation of the lobular architecture with staining of the myoepithelial markers in the peripheral myoepithelial cells surrounding almost every ductal and acinar structure, whether or not they contain normal appearing, atypical or dysplastic cells (Fig. 1g) . The staining is frequently continuous with occasional ducts having a discontinuous staining pattern, confirming the in situ nature of this process.
Follow-up information of C1 year is available in 52 cases. Five of these cases recurred (10 %), however, many of these patients have not been followed sufficiently to be able to establish long term chance of recurrence. To date, none of the patients reported have developed metastases or died secondary to disease. However, there was a recent poster presentation at the European Society of Pathology meeting in Lisbon [14] that documented a case of SPA with a long history of multiple recurrences with the last being an aggressive carcinoma and Michael Michael has seen one case of SPA with an associated malignancy (personal communication).
The etiology of SPA is still unknown. Recently Swelam [10] reported three cases of SPA that are associated with Epstein Barr virus and Skálová et al. [3] demonstrated that this is a clonal process. Therefore, SPA appears to be a neoplastic process that has histologic similarity to fibrocystic changes, sclerosing adenosis and adenosis tumors of the breast. Fifty-six percent of cases in this authors' original series had dysplastic changes consistent with a diagnosis of moderate to high-grade dysplasia/carcinomain situ [2] . Therefore, SPA should be considered a neoplasm with a low recurrence rate (approximately 10 %) and an even smaller chance of developing an associated carcinoma (approximately 2-3 %). If there is any diagnostic doubt about the correct diagnosis, careful histologic examination looking for a lobular growth pattern and lack of invasion together with immunohistochemical staining, to confirm the presence of a peripheral myoepithelial cell layer, will avoid an erroneous diagnosis of malignancy.
Cribriform Adenocarcinoma of the Tongue and Other Minor Salivary Glands
Cribriform adenocarcinoma of the tongue and other minor salivary glands (CATS), also referred to as cribriform adenocarcinoma of minor salivary gland origin, is a rare, recently recognized entity. It was first described in 1999 as a unique tumor [15] , although there are two earlier case reports of ''tubular adenocarcinoma'' of the tongue [16] and of ''papillary adenocarcinoma'' of the tongue [17] that are likely this entity. Since this initial report there has been one additional case report [18] and the largest series of these lesions to date (23 cases), was recently published [19] . The most common site of presentation is the tongue (74 %) with 9 % each involving the palate and tonsil area; 8 % arise in other intraoral sites. The mean age at presentation is 53.4 with a range of 5-85 years. These lowgrade malignant tumors initially were thought to occur exclusively in the tongue, usually on the posterior onethird. However, the series by Skálová et al. indicates that they arise in other minor salivary gland sites, including the palate, retromolar triangle area, tonsils and upper lip. Initially they were thought to arise from a thyroglossal duct anlage [15] , but currently are believed to arise from the minor salivary glands. Clinically, CATS is an infiltrative, poorly circumscribed tumor generally presenting as a submucosal mass, which infiltrates skeletal muscles and adjacent tissues, although a pedunculated lesion at the tongue base has been described [18] . A consistent clinical finding of CATS is early metastases into the cervical lymph nodes. 71 % of the 34 patients presented with cervical lymph node metastases at or very close to initial presentation and one developed late cervical lymph node metastases. No patients have developed distant metastasis to date and all patients with follow-up are alive and well without disease except for one patient who has a recurrent palatal tumor.
Treatment should be directed toward complete surgical excision with good margins; the neck should be surgically treated if there is evidence of metastatic spread/lymphadenopathy. The majority of patients have also received adjuvant radiation therapy. Chemotherapy has not been used.
Tumors are unencapsulated and may range up to 8 cm in greatest dimension. This carcinoma is arranged in lobules separated by fibrous septae with infiltration into the surrounding tissues. Both solid and microcystic growth patterns are present. The solid component often exhibits a hyperchromatic, palisaded peripheral layer, which frequently detaches from the tumor nest creating a papillary appearance. Rarely, spindling of the cells in the solid pattern has been described. The microcystic growth pattern of CATS exhibits both tubular and cribriform patterns that can be admixed (Fig. 2) . Within the lumina of the tubules, mucin can be noted, which is positive when stained with alcian blue, pH 2.5, but negative for PAS and mucicarmine. Hyalinization of the stroma may occur, and in these areas the tumor cells are arranged in cords and single tubules. Although different growth patterns are appreciated in CATS, cytologically the tumor is composed of one cell type. The cytoplasm ranges from clear to oxyphilic, containing a pale, vesicular nuclei with a ground glass quality. The nuclei often overlap similar to papillary carcinoma of the thyroid. Necrosis and hemorrhage are not usual features of CATS, and mitotic figures are rare. Lymph node metastases are histologically identical to the primary tumor. CATS is strongly immunoreactive to cytokeratin markers AE1/AE3, CAM 5.2, CK7, CK8, and CK18. S100 protein immunoreactivity is usually strong but may be patchy. C-kit (CD117) stained all tumors but is more variable; basal and myoepithelial markers are also positive but to a lesser extent and with greater variability. The proliferative activity of these tumors is low, averaging \4 %. Thyroglobulin and TTF antibody staining is negative.
Because of the prominent microscopic feature of overlapping nuclei with ground glass appearance, the differential diagnosis of CATS would include papillary thyroid carcinoma, either metastatic or from lingual thyroid. Clinically, papillary thyroid carcinoma also exhibits early metastatic spread to the cervical lymph nodes similar to CATS. However, CATS is always thyroglobulin negative and lacks colloid. Ultrastructural studies have also demonstrated myoepithelial differentiation in CATS. Polymorphous low-grade adenocarcinoma (PLGA) and the solid variant of adenoid cystic carcinoma would also be considered in the differential diagnosis of CATS. The nuclear morphology of CATS is very different from the hyperchromatic angulated nuclei seen in adenoid cystic carcinoma. Generally the solid variant of adenoid cystic carcinoma will also have more frequent mitoses. PLGA does share some histologic similarities with CATS, however, PLGA has a more diverse histology than CATS, and lacks the ground glass nuclei. Finally, early metastases to cervical lymph nodes are not a common feature of PLGA. 
Mammary Analogue Secretory Carcinoma of the Salivary Glands
Secretory carcinoma of the breast, which is also referred to as juvenile carcinoma, is a rare breast tumor predominantly arising in children or young adults; occasional cases have also been reported in adults. Four years ago, a series of 16 histologically similar carcinomas was reported in the salivary glands by Skalova et al. [20] . Both of these tumors have the same chromosomal translocation, t(12;15)(p13;q25), which leads to a fusion gene between the ETV6 gene on chromosome 12 and the NTRK3 gene on chromosome 15, which has not been found in other salivary gland tumors [20, 27] . These tumors were termed mammary analogue secretory carcinomas (MASC). Since this initial report, there have been approximately 100 additional cases published [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] . These have been previously diagnosed as unusual variants of acinic cell carcinoma, adenoid cystic carcinoma, cystadenocarcinoma, mucoepidermoid carcinoma or adenocarcinoma, NOS.
The mean age at presentation is 47 years (range 13-78); there is a slight male predominance. Approximately 60 % arose in the parotid gland, 30 % in the oral cavity, 9 % in the submandibular gland and 1 tumor arose in an accessory parotid gland. The majority of patients describe slow growing tumors over a several year period; however, a significant percentage describe recent rapid growth. Mean tumor size is 1.7-2.1 cm with a range from 0.2 to 5.5 cm. Grossly tumors are circumscribed but not encapsulated and frequently infiltrated adjacent tissues. Histologically tumors are made up of solid, microcystic, tubular and, focally, micropapillary structures containing cells with vesicular nuclei, finely granular chromatin, centrally located nucleoli and pale, eosinophilic, granular or vacuolated cytoplasm (Fig. 3) . Cellular atypia is mild and mitotic figures are usually infrequent; perineural invasion is noted in a few tumors. Tumor necrosis and vascular invasion are not found. Bubbly secretory material, that was PAS-Diastase and mucicarmine positive, is present within microcystic and tubular spaces (Fig. 3c) . Strong diffuse S100 and staining with Vimentin, CK7, CK8, CK18, CK19, Mammaglobin, Stat 5a and EMA are usually found; MUC1and MUC4 are frequently positive. Calponin, p63, CK14, CK5/ 6, EGFR, c-erbB-2, ER/PR, AR are typically negative. The proliferative rate ranges from 5 to 28 % [20] . Several recent studies demonstrated that the combination of S100, mammoglobin and especially large vacuole adipophilin staining is very helpful to eliminate almost all of the other differential diagnostic mimics of mammary analogue secretory carcinoma [24, 27, 30, 39] . This latter stain is important, as occasionally mammoglobin, similar to acinic cell carcinoma, is only focally positive in MASC. Up to 20 % of patients develop local recurrences, which rarely may extend to the temporal bone. Approximately 20 % of MASC metastasize to the cervical lymph nodes and 5 % spread to distant sites, including pleura, lung and pericardium [21] . The overall mortality is approximately 5 %; tumors that present with a higher stage are usually more aggressive and have a worse prognosis. Four cases have been associated with high-grade transformation [21, 29] . These latter tumors are larger than typical MASC, reported up to 8 cm in greatest dimension. MASC without high-grade transformation appears to be a low to intermediate grade neoplasm capable of aggressive local growth and metastatic spread. The treatment should be wide local excision with radiation added for larger/higher stage tumors. Tumors with high-grade transformation are associated with an accelerated clinical course and a poor outcome [21] .
Mucinous Myoepithelioma: A New Myoepithelioma Variant
Myoepithelial neoplasms are tumors composed almost exclusively of cells with myoepithelial differentiation.
They frequently contain spindle, plasmacytoid or epithelioid shaped cells and may have oncocytic or clear cytoplasmic features. They are uncommon, accounting for 1.5 % of all salivary gland tumors and for 2.2-5.7 % of major and minor salivary gland tumors, respectively [41] . Recently this author, together with several colleagues, described three unusual myoepithelial tumors, two benign parotid tumors and one malignant palatal tumor that contained abundant intracellular mucin material, which was termed the mucinous variant of myoepithelioma [42] . Tumor cells have abundant eosinophilic to foamy grayishblue cytoplasm, often containing intracellular mucin, mild nuclear pleomorphism, fine peppery chromatin and inconspicuous nucleoli (Fig. 4) . One benign tumor stains for cytokeratin, smooth muscle actin (SMA), S-100 and glial fibrillary acidic protein (GFAP) (Fig. 4c, d ), while the second is positive for calponin, smooth muscle myosin heavy chain, p63, S-100 and CAM 5.2. The malignant tumor is positive for calponin, cytokeratin cocktail, S-100, CK7, polyclonal carcinoembryonic antigen (focal) and GFAP.
A careful literature review found 12 similar tumors, all published as signet ring carcinomas [43] [44] [45] [46] ; all of these, c A mucicarmine stain demonstrates abundant intracellular mucin material. d, e Keratin cocktail and S100 immunohistochemical stains, respectively. The tumor also stained for SMA and GFAP; dendritic cell markers were negative (not shown) except for one tumor, have myoepithelial differentiation. In addition to these 12 cases, there are two previously published similar appearing benign tumors arising on the lip with abundant intracellular mucin and areas of plasmacytoid differentiation, but without documented myoepithelial characteristics [47, 48] . As plasmacytoid myoepitheliomas are known to occasionally not stain with myoepithelial markers [49; personal experience], it is likely that these two tumors also are mucinous myoepitheliomas.
To date, there are 17 mucinous myoepitheliomas reported; 13 arose in minor salivary glands, most frequently the palate and four in the parotid gland; the male to female ratio is approximately equal. Four are classified as benign tumors and 13 as malignant. One patient presented with a lymph node metastasis. Tumors ranged in size from 1 to 5 cm and all were treated by surgical excision. Followup information is available on only five patients, ranging from 5 months to 8 years; all are alive and well. To date, this appears to be a benign to low-grade malignancy. However, more experience with this unusual tumor is necessary to better understand its biologic behavior. One should use the same histologic criteria for this tumor to evaluate for malignancy as any other myoepithelioma, i.e. encapsulation, circumscription, destructive peripheral growth, mitotic and proliferative rates, neural invasion, tumor necrosis, and degree of pleomorphism, to decide whether or not it is benign or malignant.
